Oncogen.AI to Debut Four AI Oncology Solutions at COMPUTEX 2026

Using Agentic AI to Scale Precision Cancer Care Beyond Major Medical Centers

TAIPEI, Taiwan — Oncogen.AI, a medical AI startup founded by 40-year radiologist Professor Dr. Sandy Cheng-Yu Chen and recipient of multiple national innovation and future technology awards, will showcase its four flagship products — Rola, Pola, Mira, and Cora — for the first time at InnoVEX 2026 under the Ministry of Economic Affairs DOIT Pavilion.

Focused on oncology care, Oncogen.AI is developing an Agentic AI-powered operating layer designed to help healthcare teams manage complex cancer workflows more efficiently. The platform integrates fragmented data from imaging, pathology, genomic testing, medical records, and patient feedback into structured, actionable clinical insights, supporting multidisciplinary collaboration and precision treatment decisions.

Rather than replacing physicians, Oncogen.AI aims to reduce the heavy workload associated with data organization and clinical coordination, allowing medical professionals to focus more on treatment planning and patient care. The company believes this approach can help more hospitals establish scalable precision oncology capabilities beyond a limited number of top medical centers.

“Precision oncology remains difficult to scale because every treatment decision requires integrating vast amounts of complex medical information,” said Ping Cheng, CEO of Oncogen.AI. “We believe meaningful medical AI should support healthcare workflows behind the scenes, helping clinicians make faster, more informed, and more collaborative decisions. Through InnoVEX 2026, we look forward to exploring global partnerships that can accelerate the adoption of intelligent oncology solutions.”

Exhibition Information

Exhibition: InnoVEX 2026
Theme: Agentic AI-Powered Oncology Intelligence Ecosystem
Venue: Nangang Exhibition Center Hall 2, 4F — MOEA DOIT Pavilion
Dates: June 2–5, 2026

About Oncogen.AI

Oncogen.AI is founded by a group of clinicians, oncology experts, and AI scientists dedicated to applying Agentic AI and oncology knowledge technologies to improve complex medical workflows and enhance precision cancer care.

Media Contact

Naomi Chiu mkt@oncogenai.com
or (02) 7702-6691#301